Paper26477373
Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C and 11 others. J Ethnopharmacol, 2015. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. Papers, record 26477373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26477373
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipidemias | Major topic |
| Hypolipidemic Agents | Major topic |
| Juglandaceae | Major topic |
| Plant Extracts | Major topic |
| Animals | |
| Bile Acids and Salts | |
| Cell Line | |
| Cholesterol | |
| Cholesterol 7-alpha-Hydroxylase | |
| Diet, High-Fat | |
| Feces | |
| Humans | |
| Hydroxymethylglutaryl CoA Reductases | |
| Liver | |
| Male | |
| Mice | |
| Phytotherapy | |
| Plant Leaves | |
| Sterol O-Acyltransferase | |
| Triglycerides | |
| Sterol O-Acyltransferase 2 |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42298248 | Assembly and phylogenetic analysis of the mitochondrial genome of the Cyclocarya paliurus. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42298248 | PubMed |
| 41829956 | Compounds Contributing to the Modulation of Visceral Adiposity and Hepatic Lipid Metabolism in High-Fat-Diet-Fed Rats by Pometia pinnata (Matoa) Peel Powder: Identification of Pancreatic Lipase Inhibitors. | Nutrients | 2026 | https://conductscience.org/library/papers/41829956 | PubMed |
| 40928061 | Berberine-cinnamic acid co-crystal effect in ameliorating hyperlipidemia might be regulated through the PI3K/AKT/mTOR/SREBP-1 signaling pathway. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/40928061 | PubMed |
| 38285114 | Functional characterization of genes related to triterpene and flavonoid biosynthesis in Cyclocarya paliurus. | Planta | 2024 | https://conductscience.org/library/papers/38285114 | PubMed |
| 37860571 | Anti-diabetic effect of Ornithogalum caudatum Jacq. polysaccharides via the PI3K/Akt/GSK-3β signaling pathway and regulation of gut microbiota. | Heliyon | 2023 | https://conductscience.org/library/papers/37860571 | PubMed |
| 36742424 | Metabolomics analysis reveals amelioration effects of yellowhorn tea extract on hyperlipidemia, inflammation, and oxidative stress in high-fat diet-fed mice. | Front Nutr | 2023 | https://conductscience.org/library/papers/36742424 | PubMed |
| 36661246 | Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue. | Redox Rep | 2023 | https://conductscience.org/library/papers/36661246 | PubMed |
| 36548730 | MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36548730 | PubMed |
| 36245541 | The chemical composition and toxic effects of aqueous extracts of Cyclocarya paliurus leaves. | Front Nutr | 2022 | https://conductscience.org/library/papers/36245541 | PubMed |
| 35722005 | Micronized Dietary Okara Fiber: Characterization, Antioxidant, Antihyperglycemic, Antihyperlipidemic, and Pancreato-Protective Effects in High Fat Diet/Streptozotocin-Induced Diabetes Mellitus. | ACS Omega | 2022 | https://conductscience.org/library/papers/35722005 | PubMed |
| 35531007 | Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model. | RSC Adv | 2019 | https://conductscience.org/library/papers/35531007 | PubMed |
| 35521232 | Network pharmacology-based study of the mechanisms of action of anti-diabetic triterpenoids from Cyclocarya paliurus. | RSC Adv | 2020 | https://conductscience.org/library/papers/35521232 | PubMed |
| 35237941 | Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats. | Biol Trace Elem Res | 2023 | https://conductscience.org/library/papers/35237941 | PubMed |
| 34988228 | Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus. | J Diabetes Res | 2021 | https://conductscience.org/library/papers/34988228 | PubMed |
| 33335910 | Effects of Cyclocarya paliurus Aqueous and Ethanol Extracts on Glucolipid Metabolism and the Underlying Mechanisms: A Meta-Analysis and Systematic Review. | Front Nutr | 2020 | https://conductscience.org/library/papers/33335910 | PubMed |
| 32562054 | Hypoglycemic mechanism of polysaccharide from Cyclocarya paliurus leaves in type 2 diabetic rats by gut microbiota and host metabolism alteration. | Sci China Life Sci | 2021 | https://conductscience.org/library/papers/32562054 | PubMed |
| 31613931 | Localization and dynamic change of saponins in Cyclocarya paliurus (Batal.) Iljinskaja. | PLoS One | 2019 | https://conductscience.org/library/papers/31613931 | PubMed |
| 31583046 | Antioxidant and Hypolipidemic Activities of Acid-Depolymerised Exopolysaccharides by Termitomyces albuminosus. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31583046 | PubMed |
| 31485627 | Antiproliferative and pro‑apoptotic effects of Cyclocarya paliurus polysaccharide and X‑ray irradiation combination on SW480 colorectal cancer cells. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31485627 | PubMed |
| 31442295 | Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers. | PLoS One | 2019 | https://conductscience.org/library/papers/31442295 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP7A1 | 1581 | PubTator's text mining | https://conductscience.org/library/genes/1581 | NCBI Gene |
| SOAT2 | 8435 | PubTator's text mining | https://conductscience.org/library/genes/8435 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26477373
GET https://conductscience.org/api/papers/v1/26477373/cited_by?page=2